Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data
- PMID: 34881375
- PMCID: PMC8551838
- DOI: 10.1016/j.lanwpc.2021.100300
Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data
Keywords: HPV infection; HPV vaccine; Japanese women; cervical cancer.
Conflict of interest statement
Manako Yamaguchi, Yutaka Ueda, and Takayuki Enomoto received lecture fees from Merck Sharp and Dohme. Etsuko Miyagi received honoraria and lecture fees from Roche Diagnostics, Merck Sharp and Dohme, and Hologic Japan. All other authors report no potential conflicts.
Figures


References
-
- Simms KT, Hanley SJB, Smith MA, Keane A, Canfell K. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. The Lancet Public health. 2020;5(4):e223. -e34. - PubMed
-
- Ueda Y, Yagi A, Ikeda S, Enomoto T, Kimura T. Beyond resumption of the Japanese Government's recommendation of the HPV vaccine. The Lancet Oncology. 2018;19(12):1563–1564. - PubMed
-
- Tanaka Y, Ueda Y, Egawa-Takata T, Yagi A, Yoshino K, Kimura T. Outcomes for girls without HPV vaccination in Japan. The Lancet Oncology. 2016;17(7):868–869. - PubMed
-
- Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet (London, England) 2015;385(9987):2571. - PubMed
LinkOut - more resources
Full Text Sources